Latest News

STAT Plus: The FDA is finalizing its long-awaited rules for CBD

A version of this story first ran in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

WASHINGTON — The Food and Drug Administration appears poised to release a long-awaited enforcement policy on cannabidiol, the marijauna-adjacent compound it has struggled to regulate for over a year.

Continue to STAT Plus to read the full story…

Source link

Related posts

County Delays Georgia Sterigenics Reopening


Big Surprise Medical Bills for COVID Survivors


Medical News Today: Nicotine withdrawal symptoms and how to cope


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World